Vanda Pharmaceuticals Inc. (VNDA) stock saw a decline, ending the day at $4.94 which represents a decrease of $-0.14 or -2.76% from the prior close of $5.08. The stock opened at $5.12 and touched a ...
(RTTNews) - Vanda Pharmaceuticals (VNDA) said, on September 18, the FDA declined to approve New Drug Application of tradipitant for the treatment of symptoms in gastroparesis, providing the company ...